Filing Flows › NMI Holdings (NMIH) › Stock forecast & fair value
NMI Holdings (NMIH) stock forecast and fair value
NMI Holdings (NMIH) trades at $39.39. 8 analysts' median price target is $47.00 (+19%), from $43.00 to $54.00. Across 13 valuation methods the middle fair value is $57.91 (+47%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $43.27 | $59.29 | $73.54 | +51% |
| P/E vs peers, weighted | $61.56 | $73.47 | $94.72 | +87% |
| P/E vs peers, matched | $43.22 | $57.89 | $71.81 | +47% |
| Residual income | $42.65 | $44.28 | $46.00 | +12% |
| P/B vs ROE (insurer peers) | $23.84 | $74.69 | $125.55 | +90% |
| Analysts' price targets | $43.00 | $48.00 | $54.00 | +22% |
| Shareholder yield (dividends + buybacks) | $20.87 | $24.50 | $29.67 | -38% |
| Justified P/B (Gordon growth) | $71.53 | $88.39 | $115.66 | +124% |
| Stage-weighted value (financial (bank / insurer)) | $42.87 | $65.89 | $91.06 | +67% |
| Combined forecast (3 months) | $32.33 | $41.04 | $50.83 | +4% |
NMI Holdings' latest quarter
NMI Holdings, Q3 2026: revenue $188M (+5% year over year), operating margin 64.1%, net earnings $93.5M, operating cash flow $111M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NMIH stock?
The median of 8 analysts' 12-month targets is $47.00, +19% from $39.39; the range is $43.00 to $54.00. The average rating is buy.
What is NMI Holdings' fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $24.50 and $88.39, with a middle value of $57.91 against a price of $39.39. Each method's assumptions are on the page.
Does NMI Holdings usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is NMIH stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.